Table 2.
Effect of treatments on the blood lipid profile, body composition, and cardiorespiratory fitness in the dyslipidemic obese subjects.
| Variable | Basal | Final | p-Value |
|---|---|---|---|
| TC (mg·dL−1) | 218 ± 30 | 184 ± 33 | 0.000 |
| TAG (mg·dL−1) | 150 ± 46 | 127 ± 35 | 0.007 |
| LDL-C (mg·dL−1) | 158 ± 31 | 122 ± 34 | 0.000 |
| HDL-C (mg·dL−1) | 32.5 ± 10.9 | 38.6 ± 9.6 | 0.004 |
| BMI (kg·m−2) | 33.3 ± 3.8 | 30.1 ± 4.9 | 0.003 |
| VO2max (mL·min−1 kg−1) | 30.8 ± 5.6 | 34.7 ± 6.2 | 0.003 |
| BF (%) | 33.2 ± 6.0 | 30.5 ± 7.1 | 0.050 |
Data are expressed as mean ± SD. TC: total cholesterol, TAG: triacylglycerols; LDL-C: low-density lipoprotein-cholesterol, HDL-C: high-density lipoprotein-cholesterol, BMI: body mass index, VO2max: maximal oxygen uptake, BF: body fat.